SCHEMBL24518338

SCHEMBL24518338

CN1CCCN(c2ccc(I)cc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHKA P35790 2/20 0.62
▸ LMNA P02545 2/20 0.58
▸ NCF1 P14598 1/20 0.58
▸ ALDH1A1 P00352 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ ADRA2C P18825 1/20 0.55
▸ GFER P55789 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ PTK2B Q14289 1/20 0.55
▸ ESR2 Q92731 1/20 0.55
▸ SIRT6 Q8N6T7 1/20 0.47
▸ APP P05067 1/20 0.47
▸ F10 P00742 3/20 0.46
▸ HTR3A P46098 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1433274 0.92 MAPT (0.63) CHKALMNANCF1ALDH1A1KDM4E
SCHEMBL25888837 0.86 ALDH1A1 (0.57) CHKALMNAALDH1A1KDM4EGAA
SCHEMBL18815076 0.85 LTA4H (0.52) CHKALMNAALDH1A1KDM4EGAA
SCHEMBL82022 0.82 CHKA (0.64) CHKALMNANCF1ALDH1A1KDM4E
SCHEMBL625677 0.81 ALDH1A1 (0.54) CHKALMNAALDH1A1KDM4EGAA
SCHEMBL14345952 0.81 AKR1C3 (0.57) LMNAALDH1A1KDM4EGAAMAPT
SCHEMBL20907277 0.81 CHKA (0.62) CHKALMNANCF1ALDH1A1KDM4E
SCHEMBL24596933 0.81 CHKA (0.62) CHKALMNANCF1ALDH1A1KDM4E
SCHEMBL14922271 0.81 CHKA (0.62) CHKALMNANCF1ALDH1A1KDM4E
SCHEMBL217159 0.81 MAPT (0.85) CHKALMNANCF1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022124748-A1 PYRAZOLOPYRIMIDINE SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF CANCER-RELATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT 한국화학연구원 2022-06-16 — — WO disclosed
Send feedback